LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix International N.V. (NASDAQ:OFIX) (the "Company"), a
diversified, global medical device company, today announced that it
plans to release third quarter 2016 financial results after market close
on Monday, October 31, 2016. Brad Mason, Chief Executive Officer, and
Doug Rice, Chief Financial Officer, will host a conference call and
webcast to review the Company's results at 4:30 p.m. EDT the same day.
Interested parties may access the conference call by dialing (888)
576-4398 in the U.S. and (719) 457-2601 outside the U.S., and
referencing the conference ID 9383336. A replay of the call will be
available for two weeks by dialing (888) 203-1112 in the U.S. and (719)
457-0820 outside the U.S., and entering the conference ID 9383336. A
webcast of the conference call may be accessed by going to the Company's
website at www.orthofix.com,
by clicking on the Investors link and then the Events and Presentations
Orthofix International N.V. is a diversified, global medical device
company focused on improving patients' lives by providing superior
reconstructive and regenerative orthopedic and spine solutions to
physicians worldwide. Headquartered in Lewisville, Texas, the Company
has four strategic business units that include BioStim, Biologics,
Extremity Fixation and Spine Fixation. Orthofix products are widely
distributed via the Company's sales representatives, distributors and
its subsidiaries. In addition, Orthofix is collaborating on research and
development activities with leading clinical organizations such as
the Musculoskeletal Transplant Foundation and the Texas Scottish Rite
Hospital for Children. For more information, please visit www.orthofix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161021005143/en/
Orthofix International N.V.
Denise Landry, 214-937-2529
Source: Orthofix International N.V.
News Provided by Acquire Media